|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 46, 404-411, March 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology
Thematic Review |
Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis
The Scripps Research Institute, Department of Immunology, 10550 North Torrey Pines Road, La Jolla, CA 92037
1 To whom correspondence should be addressed. e-mail: lcurtiss{at}scripps.edu
Atherosclerosis is a chronic inflammatory response characterized by the accumulation of cells of innate and acquired immune systems within the intima of the arterial wall. Macrophages are the predominant participant in innate immune responses in atherosclerosis. Protein receptors expressed by macrophages and endothelial cells recognize components and products of microorganisms and play a vital role in innate immunity. In particular, the members of the toll-like receptor (TLR) family play a critical role in the inflammatory components of atherosclerosis. Both exogenous ligands involved in microbial recognition as well as endogenous ligands involved in sterile inflammation pathways are implicated in the pathology of atherosclerosis.
In this review, we discuss our current understanding of the role of TLRs and their coactivators in atherosclerosis, with particular emphasis on studies in atherosclerosis-prone hypercholesterolemic mice.
Abbreviations: FACS, fluorescence-activated cell sorting; IL-1, interleukin-1; LBP, LPS binding protein; LPS, lipopolysaccharide; OxLDL, oxidized LDL; OxPL, oxidized phospholipid; TIR, toll interleukin-1 receptor; TLR, toll-like receptor
Supplementary key words macrophage • lipopolysaccharide • peptidoglycan • inflammation • mouse model
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Darabian, A. Reza Amirzadegan, H. Sadeghian, S. Sadeghian, A. Abbasi, and M. Raeesi Ostial Lesions of Left Main and Right Coronary Arteries: Demographic and Angiographic Features Angiology, January 1, 2009; 59(6): 682 - 687. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Kawakami, M. Osaka, M. Aikawa, S. Uematsu, S. Akira, P. Libby, K. Shimokado, F. M. Sacks, and M. Yoshida Toll-Like Receptor 2 Mediates Apolipoprotein CIII-Induced Monocyte Activation Circ. Res., December 5, 2008; 103(12): 1402 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION J. Biol. Chem., September 5, 2008; 283(36): 24748 - 24759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Catellier, N. Aleksic, A. R. Folsom, and E. Boerwinkle Atherosclerosis Risk in Communities (ARIC) Carotid MRI Flow Cytometry Study of Monocyte and Platelet Markers: Intraindividual Variability and Reliability Clin. Chem., August 1, 2008; 54(8): 1363 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Knapp, S. von Aulock, M. Leendertse, I. Haslinger, C. Draing, D. T. Golenbock, and T. van der Poll Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor J. Immunol., March 1, 2008; 180(5): 3478 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fitzner, S. Clauberg, F. Essmann, J. Liebmann, and V. Kolb-Bachofen Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands Clin. Vaccine Immunol., January 1, 2008; 15(1): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Mitchell, M. J Paul-Clark, G. W Clarke, S. K McMaster, and N. Cartwright Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease J. Endocrinol., June 1, 2007; 193(3): 323 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Into, Y. Kanno, J.-i. Dohkan, M. Nakashima, M. Inomata, K.-i. Shibata, C. J. Lowenstein, and K. Matsushita Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells J. Biol. Chem., March 16, 2007; 282(11): 8134 - 8141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cappello, B. Saugel, K. C. Huth, A. Zwergal, M. Krautkramer, C. Furman, M. Rouis, B. Wieser, H. W. Schneider, D. Neumeier, et al. Ozonized Low Density Lipoprotein (ozLDL) Inhibits NF-{kappa}B and IRAK-1-Associated Signaling Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-q. Yan Regulation of TLR4 Expression Is a Tale About Tail. Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2582 - 2584. [Full Text] [PDF]
|
|
|
|
|
|
U. Singh, S. Devaraj, M. R. Dasu, D. Ciobanu, J. Reusch, and I. Jialal C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2469 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Trogan, J. E. Feig, S. Dogan, G. H. Rothblat, V. Angeli, F. Tacke, G. J. Randolph, and E. A. Fisher Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. PNAS, March 7, 2006; 103(10): 3781 - 3786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Katz and R. P. Shannon Bacteria and Coronary Atheroma: More Fingerprints but No Smoking Gun Circulation, February 21, 2006; 113(7): 920 - 922. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chamorro and J. Hallenbeck The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease Stroke, February 1, 2006; 37(2): 291 - 293. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Getz Bridging the innate and adaptive immune systems J. Lipid Res., April 1, 2005; 46(4): 619 - 622. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |